Gender-specific Colorectal Cancer: Epidemiologic Difference and Role of Estrogen.
10.4166/kjg.2014.63.4.201
- Author:
Hee Man KIM
1
;
Hyun Soo KIM
Author Information
1. Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea. hyskim@yonsei.ac.kr
- Publication Type:Review ; English Abstract
- Keywords:
Colorectal neoplasms;
Sex;
Estrogens;
Epidemiology;
Hormone replacement therapy
- MeSH:
Adenoma/diagnosis/epidemiology/mortality;
Colorectal Neoplasms/*diagnosis/epidemiology/mortality;
Estradiol Dehydrogenases/metabolism;
Estrogen Receptor alpha/metabolism;
Estrogen Receptor beta/metabolism;
Estrogens/*metabolism;
Humans;
Sex Factors
- From:The Korean Journal of Gastroenterology
2014;63(4):201-208
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Gender difference in the incidence of colorectal cancer is well known and has been supported by various epidemiologic studies. In Korea, women have lower incidence of colorectal cancer and adenoma, and the incidence in men has recently increased. Hormone replacement therapy in menopausal women is preventive of colorectal cancer but can cause cardiovascular diseases and breast cancer. Estrogen exerts diverse effects through estrogen receptors, ERalpha and ERbeta. ERbeta is associated with anti-proliferation and apoptosis. The ratio of ERalpha/ERbeta is important in the protection and tumorigenesis of colorectal cancer. Therefore ERbeta modulation has been investigated for preventing or treating colorectal cancer and avoiding adverse effects of estrogen at the same time. In addition, the gender-difference in the incidence of colorectal cancer should be taken into account when making guidelines on colorectal surveillance for Korean population.
